The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies

Documenti analoghi

• Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines
  di: Bovio, Federica, et al.
  Pubblicazione: (2020)
• Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.
  di: Matilde Forcella, et al.
  Pubblicazione: (2017-01-01)
• Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3
  di: Forcella, Matilde, et al.
  Pubblicazione: (2017)
• A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies
  di: Jensen, Steffen Grann, et al.
  Pubblicazione: (2021)
• Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
  di: Zlobec, Inti, et al.
  Pubblicazione: (2010)